Wilmington Funds Management’s Pfizer PFE Stock Holding History

Wilmington Funds Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	$1.81M	Sell	64,424 -92,049	-59%	-$2.62M	0.18%	136
2014 Q1	$4.77M	Sell	156,473 -41,537	-21%	-$1.24M	0.52%	62
2013 Q4	$5.75M	Sell	198,010 -116,469	-37%	-$3.39M	0.57%	36
2013 Q3	$8.57M	Sell	314,479 -13,995	-4%	-$381K	0.83%	7
2013 Q2	$8.73M	Buy	+328,474	New	+$9.08M	0.83%	13

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wilmington Funds Management's PFE Position: Q2 2014 in Review

Wilmington Funds Management reduced its Pfizer (PFE) stake by 59% in Q2 2014, selling an estimated $2.62M and leaving 64,424 shares worth $1.81M. The position accounts for 0.18% of the portfolio, ranked #136.

Wilmington Funds Management first reported a position in PFE in Q2 2013 and has held it in 5 quarters since. The position peaked at $8.73M in Q2 2013. 1,747 funds tracked by Wall St. Rank hold PFE as of Q2 2014.

Wilmington Funds Management held 64,424 shares of Pfizer worth $1.81M as of Q2 2014.
Wilmington Funds Management sold 92,049 Pfizer shares in Q2 2014, an estimated $2.62M.
Pfizer made up 0.18% of Wilmington Funds Management's portfolio in Q2 2014, its #136 holding.
Wilmington Funds Management first reported a position in Pfizer in Q2 2013 and has held it in 5 quarters since.
Wilmington Funds Management's Pfizer position peaked at $8.73M in Q2 2013.
1,747 funds tracked by Wall St. Rank held Pfizer as of Q2 2014.

Based on Wilmington Funds Management's 13F filing for Q2 2014, filed 13 Aug 2014.